In this regard, Yang et al. [147] proposed that dual inhibition of PI3K/mTOR and CDK pathways via small molecule drugs could promote caspase-3-induced pyroptosis in tumor cells, thereby enhancing the effectiveness of ICB therapies. Here, CASP3 is linked to neoplasm.